ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by an Associate of a Director of the Company
Dealing in Securities by an Associate of a Director of the Company
ASPEN PHARMACARE HOLDINGS LIMITED
Incorporated in the Republic of South Africa
Registration number: 1985/002935/06
JSE Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen" or "the Group")
DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR OF THE COMPANY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:
Director: Stephen Bradley Saad
Associate: K2019068922 (South Africa) Pty Ltd of which Stephen Bradley Saad is a
director
Date of transaction: 08 May 2025
Nature of transaction: On-market purchase of shares
Number of securities: 700,037
Price per security: 11,845.08 cents
Value of Transaction: R82,919,942.68
Class of securities: Ordinary shares
Nature of interest: Indirect beneficial
Clearance obtained: Yes
09 May 2025
Sponsor:
Investec Bank Limited
Date: 09-05-2025 02:55:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
